{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:53:27Z","timestamp":1792518807812,"version":"4.5.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1093\/ndt\/gft251","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T03:36:30Z","timestamp":1377056190000},"page":"833-842","source":"Crossref","is-referenced-by-count":104,"title":["Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial"],"prefix":"10.1093","volume":"29","author":[{"given":"Jane E.","family":"Onken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Bregman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Buerkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Hamerski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mangoo-Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos O.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Edward","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeh Y.","family":"Qunibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelia","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence T.","family":"Goodnough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,8,20]]},"reference":[{"key":"key\n\t\t\t\t20170518092654_GFT251C1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041552-200205000-00011","article-title":"Epidemiology of anemia associated with chronic renal insufficiency","volume":"11","author":"Hsu","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20170518092654_GFT251C2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988\u20131994)","volume":"162","author":"Astor","year":"2002","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170518092654_GFT251C3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.me.41.020190.002025","article-title":"Treatment of the anemia of chronic renal failure with recombinant human erythropoietin","volume":"41","author":"Adamson","year":"1990","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t20170518092654_GFT251C4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(97)90192-X","article-title":"Iron management in end-stage renal disease","volume":"29","author":"Fishbane","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518092654_GFT251C5","article-title":"National Kidney Foundation: NKF-KDOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000 (Part IV)"},{"key":"key\n\t\t\t\t20170518092654_GFT251C6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21656","article-title":"FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease","volume":"85","author":"Lu","year":"2010","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20170518092654_GFT251C7","article-title":"The first head-to-head comparison study (ferumoxytol compared to iron sucrose trial) of the safety and efficacy of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with chronic kidney disease","author":"Macdougall"},{"key":"key\n\t\t\t\t20170518092654_GFT251C8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric carboxymaltose: a review of its use in iron-deficiency anaemia","volume":"69","author":"Lyseng-Williamson","year":"2009","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170518092654_GFT251C9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092654_GFT251C10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/gfs528","article-title":"Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study","volume":"28","author":"Charytan","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092654_GFT251C11","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518092654_GFT251C12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170518092654_GFT251C13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000275286.03283.18","article-title":"Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial","volume":"110","author":"Van Wyck","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170518092654_GFT251C14","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t20170518092654_GFT251C15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/annonc\/mds338","article-title":"Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia","volume":"24","author":"Steinmetz","year":"2013","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20170518092654_GFT251C16","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/ndt\/gfq218","article-title":"Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design","volume":"25","author":"Szczech","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092654_GFT251C17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518092654_GFT251C18","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20170518092654_GFT251C19","doi-asserted-by":"crossref","first-page":"665A","DOI":"10.2215\/CJN.03920808","article-title":"Intravenous (i.v.) ferric carboxymaltose (FCM) versus i.v. iron sucrose (ISC) in the treatment of iron deficiency anemia (IDA) in patients undergoing maintenance haemodialysis (HD)","volume":"20","author":"Evenepoel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092654_GFT251C20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.crohns.2010.01.007","article-title":"The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective","volume":"4","author":"Bager","year":"2010","journal-title":"J Crohn\u2019s and Colitis"},{"key":"key\n\t\t\t\t20170518092654_GFT251C21","doi-asserted-by":"crossref","first-page":"e45604","DOI":"10.1371\/journal.pone.0045604","article-title":"Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency","volume":"7","author":"Calvet","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170518092654_GFT251C22","article-title":"FDA Advisory Committee Briefing Document, Drug Safety and Risk Management Committee, 1 February 2008","author":"U.S. Food and Drug Administration"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/29\/4\/833\/17171979\/gft251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:55:43Z","timestamp":1715900143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gft251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,20]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,8,20]]},"published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gft251","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,20]]}}}